Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sterol/stanol ester spreads

This article was originally published in The Tan Sheet

Executive Summary

McNeil Benecol and Lipton Take Control sales rose 31% and 14.4%, respectively, in 2000, according to Chicago-based IRI. Stanol ester-containing Benecol posted sales of $26.7 mil. for year, while Take Control recorded sales of $19.3 mil. in food, drug and mass outlets. Lipton's Take Control Light generated sales of $9.7 mil. Cholesterol-lowering functional foods soon may face added competition from Altus Foods, which is launching a line of Phytrol-based products developed by Forbes Medi-Tech; Reducol-maker Novartis also has petitioned FDA to allow cholesterol-reduction claims for phytosterol substances to be more flexible (1"The Tan Sheet" Dec. 11, 2000, pp. 3-5)

Related Content

Topics

UsernamePublicRestriction

Register

PS092210

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel